Pemoline in the Treatment of Stimulant Dependence - 5

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Withdrawn
Phase 2

Conditions

Cocaine-Related Disorders

Treatments

Drug: Pemoline

Study type

Interventional

Funder types

NIH

Identifiers

NCT00000340
Y01-3-0010-5
NIDA-3-0010-5

Details and patient eligibility

About

The purpose of this study is to assess the efficacy of pemoline in treating cocaine and/or methamphetamine dependent adults with comorbid Adult Attention Deficit Hyperactivity Disorder (ADHD).

Sex

All

Ages

21 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

M/F ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent.

Exclusion criteria

Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems